These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 6086714)
1. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies. Baker JR; Lukes YG; Burman KD J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714 [TBL] [Abstract][Full Text] [Related]
2. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay. Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364 [TBL] [Abstract][Full Text] [Related]
3. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related]
4. Photoaffinity labelling of the porcine thyrotropin receptor--effect of Graves' immunoglobulin G and anti-TSH anti-idiotypic antibodies. Bakó G; Islam MN; Farid NR Clin Invest Med; 1985; 8(2):152-9. PubMed ID: 2870832 [TBL] [Abstract][Full Text] [Related]
5. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. Heyma P; Harrison LC J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581 [TBL] [Abstract][Full Text] [Related]
6. Antithyrotropin antibodies in the sera of Graves' disease patients. Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314 [TBL] [Abstract][Full Text] [Related]
7. Anti-idiotypic antibodies as probes for hormone-receptor interaction. Farid NR; Briones-Urbina R; Islam MN Can J Biochem Cell Biol; 1984 Nov; 62(11):1255-67. PubMed ID: 6084548 [TBL] [Abstract][Full Text] [Related]
8. Use of anti-idiotypic antibodies as probes for the interaction of TSH subunits with its receptor. Briones-Urbina R; Islam MN; Ivanyi J; Farid NR J Cell Biochem; 1987 Jul; 34(3):151-62. PubMed ID: 3497159 [TBL] [Abstract][Full Text] [Related]
9. Biological activity of anti-thyrotropin anti-idiotypic antibody. Islam MN; Pepper BM; Briones-Urbina R; Farid NR Eur J Immunol; 1983 Jan; 13(1):57-63. PubMed ID: 6299753 [TBL] [Abstract][Full Text] [Related]
10. Studies of possible antiidiotypic control mechanisms in Graves' disease. Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588 [TBL] [Abstract][Full Text] [Related]
11. A new serum-based assay for fat cell-binding immunoglobulins: application to the detection of the thyrotropin receptor antibodies of Graves' disease. Shinozawa T; Villadolid MC; Ingbar SH J Clin Endocrinol Metab; 1986 Jan; 62(1):10-5. PubMed ID: 2999174 [TBL] [Abstract][Full Text] [Related]
12. In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease. Balázs C; Molnár I Acta Microbiol Immunol Hung; 1995; 42(2):163-9. PubMed ID: 7551709 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients. Hill BL; Erlanger BF Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350 [TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators. Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871 [TBL] [Abstract][Full Text] [Related]
16. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease. Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548 [TBL] [Abstract][Full Text] [Related]
17. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody. Ochi Y; Kajita Y; Hamazu M; Nagata A Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785 [TBL] [Abstract][Full Text] [Related]
18. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759 [TBL] [Abstract][Full Text] [Related]
19. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease. Shinozawa T; Villadolid MC; Ingbar SH J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173 [TBL] [Abstract][Full Text] [Related]
20. An anti-idiotypic antibody against Graves' IgG. Hawe BS; Davies TF; Farid NR Immunol Lett; 1987 Jun; 15(2):95-100. PubMed ID: 2442098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]